Skip to main content
CHE logo

CHE · Chemed Corp · Metrics

Track CHE — free
Market Cap
$7.12B
Shares
13.01M
Volume · Nov 19 24.83K Avg daily vol (3M) 151.72K

CHE metrics

113 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$546.72
Market cap
$7.12B

Price action

23 metrics
Price change (1W)
-0.7%
Price change (30D)
+7.6%
Price change (3M)
+2.1%
Price change (6M)
+23.8%
Price change (YTD)
+27.8%
Price change (1Y)
+25.6%
Trailing year
Price change (5Y)
+8.8%
52-week high
$552.72
52-week low
$368.59
Change from 52-week high
-1.1%
Change from 52-week low
+48.3%
Annualized volatility
28.5%
Annualized volatility (3M)
22.6%
Implied volatility (30D)
28.3%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.1
RSI (14D)
59.3
Price vs SMA 50
+5.4%
Price vs SMA 200
+16.5%
Avg volume (3M)
151,712
Relative volume
1.1
Average dollar volume
$79.06M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
13.01M

Valuation

12 metrics
P / E (TTM)
26.2
Trailing earnings · reciprocal yield 3.8%
PEG ratio
1.2
EV / revenue
2.7×
reciprocal yield 36.4%
EV / EBITDA
16.7×
reciprocal yield 6.0%
EV / EBIT
19.7×
reciprocal yield 5.1%
P / sales
2.7×
reciprocal yield 37.4%
P / book
8.3
reciprocal yield 12.1%
FCF yield
4.2%
TTM · current market cap
Buyback yield
7.4%
P / FCF
24.1
reciprocal yield 4.2%
P / operating cash flow
19.6
reciprocal yield 5.1%
Earnings yield
4.0%

Historical valuation

8 metrics
P / E historical average (3Y)
26.7×
reciprocal yield 3.7%
P / E historical average (5Y)
28.3×
reciprocal yield 3.5%
EV / revenue historical average (3Y)
3.0×
reciprocal yield 33.6%
EV / revenue historical average (5Y)
3.2×
reciprocal yield 31.0%
EV / EBIT historical average (3Y)
20.5×
reciprocal yield 4.9%
EV / EBIT historical average (5Y)
21.3×
reciprocal yield 4.7%
EV / EBITDA historical average (3Y)
17.3×
reciprocal yield 5.8%
EV / EBITDA historical average (5Y)
18.1×
reciprocal yield 5.5%

Dividends & buybacks

7 metrics
Dividend yield
0.5%
Trailing 12 months
Payout ratio
11.9%
Shareholder yield
7.8%
Dividend / share (TTM)
$2.60
Dividend growth YoY
+18.2%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-11-16

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-28

Profitability

9 metrics
Gross margin
33.5%
Operating margin
13.9%
Trailing 12 months
Net margin
10.6%
Gross profit (TTM)
$892.52M
Operating profit (TTM)
$370.86M
Net income (TTM)
$282.40M
Trailing 12 months
Diluted EPS (TTM)
$20.87
FCF margin
11.1%
Effective tax rate
26.1%

Per share

11 metrics
Revenue per diluted share (TTM)
$197.39
Gross profit per diluted share (TTM)
$66.19
Operating profit per diluted share (TTM)
$27.48
EBITDA per diluted share (TTM)
$32.49
Net income per diluted share (TTM)
$20.92
Operating cash flow per diluted share (TTM)
$26.73
Free cash flow per diluted share (TTM)
$21.72
Capital expenditures per diluted share (TTM)
$5.01
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$66.19

Growth

11 metrics
Revenue growth YoY
+10.6%
Year over year
Net income growth YoY
+11.5%
Revenue (TTM)
$2.66B
Trailing 12 months
EPS growth YoY
+22.2%
Shares change YoY
-8.8%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.8%
Revenue CAGR (5Y)
+4.0%
EPS CAGR (3Y)
+3.5%
EPS CAGR (5Y)
-1.2%
FCF CAGR (3Y)
+8.8%
FCF CAGR (5Y)
-5.4%

Quality

14 metrics
Return on equity
32.8%
Return on assets
16.4%
Debt / equity
0.3
Current ratio
1.1
EBITDA (TTM)
$438.45M
Free cash flow (TTM)
$295.59M
Quick ratio
1.1
Interest coverage
75.4
Net debt / EBITDA
0.4
Return on invested capital
26.1%
Trailing 12 months
Net cash
−$187.57M
Latest balance sheet
Cash & equivalents
$48.43M
Total assets
$1.72B
Total debt
$236.00M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$363.15M
Capital expenditures (TTM)
$67.56M
R&D (TTM)
—
SG&A (TTM)
$446.50M
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
545
13F filer change QoQ
+11
Institutional ownership
102.4%
Conviction holders (share of 13F filers)
0.4%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+2.1%
Holder tenure
17.6
Price vs estimated holder cost
+2.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
25.7%

Short interest

3 metrics
Short interest
6.1%
Latest settlement · 5.1 days to cover
Days to cover
5.1d
Short-squeeze score
75 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$5.77M
Insider-sentiment score
16 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 19584 CUSIP 16359R103 13F (30d) 559 filings 500 filers Visit website Investor relations